4/A//SEC Filing
Winters Chad 4/A
Accession 0001127602-23-030255
CIK 0000105770other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 12:54 PM ET
Size
11.9 KB
Accession
0001127602-23-030255
Insider Transaction Report
Form 4/AAmended
Winters Chad
VP, Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-04$173.22/sh+341$59,068→ 2,282.698 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-12-04−341→ 1,571 totalExercise: $173.22From: 2021-02-18Exp: 2030-02-18→ Stock Options (Right to Buy) (341 underlying) - Exercise/Conversion
Common Stock
2023-12-04$143.43/sh+456$65,404→ 1,941.698 total - Sale
Common Stock
2023-12-04$349.00/sh−1,013$353,541→ 1,269.698 total - Exercise/Conversion
Stock Options (Right to Buy)
2023-12-04−456→ 0 totalExercise: $143.43From: 2020-10-29Exp: 2029-10-29→ Stock Options (Right to Buy) (456 underlying)
Footnotes (1)
- [F1]This is a revision to accurately reflect option exercises and sales that Chad Winters requested on December 1, 2023 that were completed on December 4, 2023 due to a record-keeping system outage.
Documents
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001811424
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 12:54 PM ET
- Size
- 11.9 KB